Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, ...
Discover the latest breakthroughs in multiple myeloma treatment, including CAR T-cell therapies and promising new options for ...
Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...
At ASH 2025, investigators reported early results from the first-in-human phase 1 inMMyCAR study evaluating KLN-1010, an ...
Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...
U.S. IND represents the second regulatory clearance for KLN-1010 and enables the first multi-center clinical trial in the U.S ...
Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...
Johnson & Johnson has submitted a Type II variation application to the European Medicines Agency for an extension of ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The good news, I guess, is that we have ...
Shortly after finding out his wife was pregnant with their son, Guillaume Arnould got terrible news about his own health: He had multiple myeloma, a rare blood cancer. He was just 33 years old. The ...
Care partners for multiple myeloma patients emphasize that managing their own mental health is not a luxury, but a necessity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback